Arcutis BiotherapeuticsARQT
那斯達克 · USD
23.89
+0.51
(+2.16%)
收盤 09/12 03:59 (UTC+8)
09/12 03:59 (UTC+8)
Arcutis BiotherapeuticsARQT
23.89
+0.51
(+2.16%)
財務數據
損益表
- 0.50
- 0.31
- 0.45
- 0.71
- 0.66
- 0.82
- 0.99
- 1.30
- 1.05
- 1.30
- 266.47
- -37.75
- 45.04
- 59.45
- -7.73
- 23.78
- 21.74
- 30.52
- -18.61
- 23.21
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 129,861 | 105,398 | 129,503 | 99,219 | 81,504 | 65,846 | 71,360 | 44,755 | 30,858 | 49,569 |
營業成本 | 10,939 | 9,784 | 11,688 | 8,685 | 7,492 | 8,830 | 6,905 | 5,503 | 3,464 | 3,256 |
營業毛利 | 118,922 | 95,614 | 117,815 | 90,534 | 74,012 | 57,016 | 64,455 | 39,252 | 27,394 | 46,313 |
營業費用 | 102,493 | 104,703 | 99,428 | 82,008 | 88,623 | - | 72,087 | - | - | 77,935 |
研發費用 | 20,355 | 30,627 | 20,451 | 19,604 | 19,453 | 17,543 | 14,480 | 19,501 | 19,298 | 23,141 |
推銷及管理費用 | 82,138 | 74,076 | 78,977 | 62,404 | 69,170 | 64,002 | 57,607 | 58,817 | 58,173 | 54,794 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 16,429 | -9,089 | 18,387 | 8,526 | -14,611 | -24,529 | -7,632 | -39,066 | -50,077 | -31,622 |
其他收入及費用 | 2,122 | 2,255 | 2,479 | 2,035 | 2,096 | 2,730 | 2,718 | 4,182 | 5,229 | 4,044 |
利息費用 | 3,406 | 4,368 | 3,001 | 3,071 | 3,029 | 2,982 | 5,551 | 6,653 | 7,484 | 7,480 |
稅前純益 | 15,145 | -11,202 | 17,865 | 7,490 | -15,544 | -24,781 | -10,465 | -41,537 | -52,332 | -35,058 |
所得稅 | 136 | 93 | 470 | 80 | 342 | 279 | 323 | - | - | 324 |
稅後純益 | 15,009 | -11,295 | 17,395 | 7,410 | -15,886 | -25,060 | -10,788 | -41,537 | -52,332 | -35,382 |
基本每股稅後盈餘(元) | 0.11 | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 |
稀釋每股稅後盈餘(元) | 0.12 | -0.09 | 0.13 | 0.06 | -0.12 | -0.20 | -0.08 | -0.33 | -0.43 | -0.32 |
基本平均股數(千股) | 130522.00 | 129365.00 | 128251.00 | 127623.00 | 126997.00 | 126037.00 | 124918.00 | 124302.00 | 123481.00 | 111048.00 |
稀釋平均股數(千股) | 135898.00 | 129365.00 | 135635.00 | 132885.00 | 126997.00 | 126037.00 | 124918.00 | 124302.00 | 123481.00 | 111048.00 |
還原基本每股稅後盈餘(元) | 0.11 | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 |
還原稀釋每股稅後盈餘(元) | 0.12 | -0.09 | 0.13 | 0.06 | -0.12 | -0.20 | -0.08 | -0.33 | -0.43 | -0.32 |
還原基本平均股數(千股) | 130,522 | 129,365 | 128,251 | 127,623 | 126,997 | 126,037 | 124,918 | 124,302 | 123,481 | 111,048 |
還原稀釋平均股數(千股) | 135,898 | 129,365 | 135,635 | 132,885 | 126,997 | 126,037 | 124,918 | 124,302 | 123,481 | 111,048 |
EBITDA(千元) | 18,891 | -6,454 | 21,440 | 10,572 | -12,647 | -19,526 | -5,057 | -35,144 | -46,885 | -28,945 |